These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 17995975)

  • 21. Subconjunctival bevacizumab for corneal neovascularization.
    Doctor PP; Bhat PV; Foster CS
    Cornea; 2008 Oct; 27(9):992-5. PubMed ID: 18812760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of subconjunctival suramin on corneal neovascularization in rabbits.
    Lee HS; Chung SK
    Cornea; 2010 Jan; 29(1):86-92. PubMed ID: 19907290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NK1 receptor antagonists as a new treatment for corneal neovascularization.
    Bignami F; Giacomini C; Lorusso A; Aramini A; Rama P; Ferrari G
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6783-94. PubMed ID: 25228541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of tacrolimus and bevacizumab on corneal neovascularization in rabbits.
    Park JH; Joo CK; Chung SK
    Cornea; 2015 Apr; 34(4):449-55. PubMed ID: 25651492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of bevacizumab on corneal neovascularization in rabbits.
    Kim WJ; Jeong HO; Chung SK
    Korean J Ophthalmol; 2010 Aug; 24(4):230-6. PubMed ID: 20714387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs.
    Koenig Y; Bock F; Kruse FE; Stock K; Cursiefen C
    Cornea; 2012 Aug; 31(8):887-92. PubMed ID: 22362005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of topical bevacizumab on corneal neovascularization.
    Kim SW; Ha BJ; Kim EK; Tchah H; Kim TI
    Ophthalmology; 2008 Jun; 115(6):e33-8. PubMed ID: 18439681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The anti-inflammatory effect of subconjunctival bevacizumab on chemically burned rat corneas.
    Oh JY; Kim MK; Shin MS; Lee HJ; Lee JH; Wee WR
    Curr Eye Res; 2009 Feb; 34(2):85-91. PubMed ID: 19219678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea pigs.
    Hurmeric V; Mumcuoglu T; Erdurman C; Kurt B; Dagli O; Durukan AH
    Cornea; 2008 Apr; 27(3):357-62. PubMed ID: 18362668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of topical infliximab on corneal neovascularization in rabbits.
    Kim JW; Chung SK
    Cornea; 2013 Feb; 32(2):185-90. PubMed ID: 23146933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subconjunctival bevacizumab injection for corneal neovascularization.
    Bahar I; Kaiserman I; McAllum P; Rootman D; Slomovic A
    Cornea; 2008 Feb; 27(2):142-7. PubMed ID: 18216566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of bevacizumab on corneal neovascularization in experimental rabbit model.
    Ahmed A; Berati H; Nalan A; Aylin S
    Clin Exp Ophthalmol; 2009 Sep; 37(7):730-6. PubMed ID: 19788671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical and subconjunctival bevacizumab for corneal neovascularization in an experimental rat model.
    Öner V; Küçükerdönmez C; Akova YA; Çolak A; Karalezli A
    Ophthalmic Res; 2012; 48(3):118-23. PubMed ID: 22538642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of subconjuctival combined treatment of bevacizumab and triamcinolone acetonide on corneal neovascularization in rabbits.
    Kang S; Chung SK
    Cornea; 2010 Feb; 29(2):192-6. PubMed ID: 20098156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal neovascularization.
    You IC; Kang IS; Lee SH; Yoon KC
    Acta Ophthalmol; 2009 Sep; 87(6):653-8. PubMed ID: 19021596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subconjunctival bevacizumab for corneal neovascularization.
    Zaki AA; Farid SF
    Acta Ophthalmol; 2010 Dec; 88(8):868-71. PubMed ID: 19519730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alkali burn-induced synthesis of inflammatory eicosanoids in rabbit corneal epithelium.
    Conners MS; Urbano F; Vafeas C; Stoltz RA; Dunn MW; Schwartzman ML
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):1963-71. PubMed ID: 9331260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms controlling the effects of bevacizumab (avastin) on the inhibition of early but not late formed corneal neovascularization.
    Chen WL; Chen YM; Chu HS; Lin CT; Chow LP; Chen CT; Hu FR
    PLoS One; 2014; 9(4):e94205. PubMed ID: 24714670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of canstatin in alkali burn-induced corneal neovascularization.
    Wang Y; Yin H; Chen P; Xie L; Wang Y
    Ophthalmic Res; 2011; 46(2):66-72. PubMed ID: 21242701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of corneal neovascularization after alkali burn: comparison of different doses of bevacizumab in monotherapy or associated with dexamethasone.
    Hoffart L; Matonti F; Conrath J; Daniel L; Ridings B; Masson GS; Chavane F
    Clin Exp Ophthalmol; 2010 May; 38(4):346-52. PubMed ID: 21077280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.